Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2025-12-25 @ 3:39 AM
NCT ID:
NCT00106002
Brief Title:
Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer
Official Title:
A Phase II Study of Alimta as First Line Chemotherapy for Advanced or Metastatic Breast Cancer
Study:
NCT00106002
Protocol Section:
NCT00106002